SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-003836
Filing Date
2018-05-03
Accepted
2018-05-03 08:46:10
Documents
50
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q glyc-20180331x10q.htm 10-Q 963485
2 EX-31.1 glyc-20180331ex311b87b96.htm EX-31.1 18171
3 EX-31.2 glyc-20180331ex3129f2789.htm EX-31.2 17222
4 EX-32.1 glyc-20180331ex3212bde24.htm EX-32.1 10253
  Complete submission text file 0001558370-18-003836.txt   3912919

Data Files

Seq Description Document Type Size
5 EX-101.INS glyc-20180331.xml EX-101.INS 805108
6 EX-101.SCH glyc-20180331.xsd EX-101.SCH 29057
7 EX-101.CAL glyc-20180331_cal.xml EX-101.CAL 27693
8 EX-101.DEF glyc-20180331_def.xml EX-101.DEF 109579
9 EX-101.LAB glyc-20180331_lab.xml EX-101.LAB 262784
10 EX-101.PRE glyc-20180331_pre.xml EX-101.PRE 209085
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36177 | Film No.: 18801937
SIC: 2834 Pharmaceutical Preparations